University of Miami Miller School of Medicine clinical investigators from its Diabetes Research Institute and Vertex Pharmaceuticals initiated a potentially path breaking clinical trial for…
VX-880, formerly known as STx-02, is an investigational allogeneic human stem cell-derived islet cell therapy that is being evaluated for patients who have type 1…
T1D Exchange has launched a population health surveillance study of individuals with type diabetes (T1D) who are suspected or confirmed to have contracted COVID-19. The…
The world’s first licensed, downloadable artificial pancreas app for those with type 1 diabetes was launched recently—based on the research of Professor Roman Hovorka with…
Scientists have mapped the thymus, a gland in the chest that makes disease-fighting white blood cells, across the human life span. This “cell atlas” could…
What roles do gut microbes and viruses play in triggering the autoimmunity of Type 1 diabetes? The G. Harold and Leila Y. Mathers Foundation would like…
University of New South Wales (UNSW) Sydney, along with partners, have been awarded $8.25 million to further a study titled The Environmental Determinants of Islet Autoimmunity…
University of California, Irvine (UCI) and its Clinical Islet Program led by Dr. Jonathan Lakey and Diomics Corporation, a leader in forensic, diagnostic and therapeutic…
The Environmental Determinants of Diabetes in the Young (TEDDY) study is the largest prospective observational cohort study of newborns with increased genetic risk for Type 1…
Clinical investigative sponsors claim a breathing artificial pancreas, created using lung tissue from a pig, will commence in clinical trials within 12 months. It is…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
